Portuguese, Andrew J. http://orcid.org/0000-0003-1010-4578
Gauthier, Jordan
Tykodi, Scott S.
Hall, Evan T.
Hirayama, Alexandre V. http://orcid.org/0000-0001-7980-3882
Yeung, Cecilia C. S.
Blosser, Christopher D.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (T32 HL007093)
Article History
Received: 12 September 2022
Revised: 15 December 2022
Accepted: 20 December 2022
First Online: 27 December 2022
Competing interests
: AP has disclosed receiving support from an institutional training grant from the National Heart, Lung, and Blood Institute (T32 HL007093). JG has disclosed receiving research funding from Sobi, Juno Therapeutics, and Celgene; receiving consulting fees from Eusapharma, JMP, Larvol, and Multerra Bio; and serving on advisory boards for Legend Biotech and Janssen. ST has disclosed receiving grant/research support from AVEO Oncology, Bristol-Myers Squibb, Merck & Co., Genentech, Pfizer, Nektar Therapeutics, Exelixis, and Jounce Therapeutics; receiving consulting fees from PLS Group Services, Exelixis, Merck & Co., Bristol-Myers Squibb, and Intellisphere LLC; serving on an advisory board for Merck & Co., Exelixis, and Bristol-Myers Squibb; receiving honoraria from Natera and General Dynamics Information Technology; and serving as a consultant for Targeted Oncology. CB has disclosed serving as a consultant for Natera and Sandoz, and participating in research funded by Natera. EH has disclosed serving as a principal investigator for Neoleukin Therapeutics, ImCheck Therapeutics, Checkpoint Pharmaceuticals, and Nektar. AH has disclosed receiving research funding from Juno Therapeutics, and NanoString Technologies; receiving honoraria from Bristol-Myers Squibb and Novartis. CY has disclosed receiving grant/research support from Pfizer, Sensei Biotherapeutics, Exicure, Incyte, Signal One, Lonza, OBI; receiving consulting fees from Twinstrands; serving on an advisory board for Merck & Co., and Eli-Lily. The remaining authors have disclosed no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.